98%
921
2 minutes
20
Objective: The Coronary Artery Risk Detection in Appalachian Communities (CARDIAC) project surveyed cardiometabolic risk factors to identify risk for adult heart disease through a school-based program. This current investigation determined the follow-up status of children who were identified with elevated low-density lipoprotein cholesterol (LDL-C) level that suggests a diagnosis of familial hypercholesterolemia (FH). We hypothesized deficient follow-up of persons identified with probable FH from screening LDL-C in West Virginia (WV) fifth-grade classes. Other markers suggested ongoing health care for many of these persons.
Study Design: Between 1998 and 2016, 60 404 children in the fifth grade had LDL-C levels identified through the CARDIAC Project. Of the 632 children who had probable FH, 398 were subsequently identified through the electronic health record, phone calls, and mail surveys. The institutional review board at West Virginia University approved verbal consent for follow-up. Information obtained included any medical care, medications including cholesterol-lowering (CLM), and family history of cardiac events.
Results: Of the 398 children previously screened in WV CARDIAC Project, 75 (19%) had follow-up lipid panels. Fifty-six subjects not on a CLM had an LDL-C that was 27.96 ± 93.4 mg/dL lower than the fifth-grade baseline ( < .001), whereas no significant change was seen in those on a CLM. Overall, 46% of participants indicated no health care interaction after screening, and 34% of participants showed interaction without a follow-up lipid panel.
Conclusions: A suboptimal midterm effect of FH identification was noted in fifth graders. Universal screening as was offered in WV must be linked to a follow-up system that engages primary providers, parents, and children to embrace life-saving preventive practices.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11824669 | PMC |
http://dx.doi.org/10.1016/j.jpedcp.2024.200109 | DOI Listing |
Nat Aging
September 2025
Aging Biomarker Consortium (ABC), Beijing, China.
The global surge in the population of people 60 years and older, including that in China, challenges healthcare systems with rising age-related diseases. To address this demographic change, the Aging Biomarker Consortium (ABC) has launched the X-Age Project to develop a comprehensive aging evaluation system tailored to the Chinese population. Our goal is to identify robust biomarkers and construct composite aging clocks that capture biological age, defined as an individual's physiological and molecular state, across diverse Chinese cohorts.
View Article and Find Full Text PDFAm J Prev Med
September 2025
Social Determinants of Obesity and Cardiovascular Risk Laboratory, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA; Intramural Research Program, National Institute on Minority Health Disparities, National Institutes of Health, Bethesda, Maryland, USA
Background: Epidemiologic studies have linked neighborhood socioeconomic conditions to health. However, few have examined neighborhood structural investment (NSI) influences on cardiometabolic risk markers across urban environments. This study investigated whether NSI varies by historic redlining, associations between NSI and the prevalence of obesity, diabetes, and coronary heart disease (CHD) and whether redlining's effect on obesity, diabetes, and CHD prevalence are mediated by neighborhood structural investment.
View Article and Find Full Text PDFJACC Heart Fail
September 2025
Cardiovascular Pathology, Department of Cardiac, Thoracic Vascular Sciences and Public Health, University of Padova, Padova, Italy. Electronic address:
JACC Heart Fail
September 2025
British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom; Department of Internal Medicine, School of Clinical Medicine, Hangzhou Normal University, Hangzhou, China. Electronic address:
Apoptosis
September 2025
The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, 182 Chunhui Road, Longmatan District, Luzhou, 646000, China.
Diabetic cardiomyopathy (DCM) is a severe cardiovascular complication of diabetes mellitus, characterized by pathological changes such as cardiomyocyte hypertrophy, necrosis, and myocardial fibrosis, which can ultimately lead to heart failure. However, its underlying mechanisms remain incompletely understood, limiting the development of effective therapeutic approaches. In recent years, the critical roles of oxidative stress and ferroptosis in the pathogenesis of DCM have attracted increasing attention.
View Article and Find Full Text PDF